Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cardiovascular (CV) Risk”

92 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 92 results

Not applicableStudy completedNCT01636271
What this trial is testing

SB-480848 in Major Adverse Cardiovascular Events - Integrated Summary of Efficacy and Safety From the STABILITY Trial (LPL100601) and the SOLID-TIMI-52 Trial (SB-480848/033)

Who this might be right for
Coronary Heart Disease
GlaxoSmithKline 28,855
Not applicableUnknownNCT01236820
What this trial is testing

A Study Using L5 as a Risk Factor of Cardiovascular (CV) Disease in Chronic Renal and Dialytic Patients

Who this might be right for
Cardiovascular DiseaseChronic Kidney Disease PatientsHemodialytic Patients+2 more
China Medical University Hospital 48
Not applicableLooking for participantsNCT07166822
What this trial is testing

The Role of Mobile Apps in Promoting Cardiovascular Health and Motivation to Exercise During Pregnancy

Who this might be right for
Cardiovascular (CV) RiskExercise
Old Dominion University 50
Large-scale testing (Phase 3)Study completedNCT02525939
What this trial is testing

Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACS

Who this might be right for
Acute Coronary Syndrome
DalCor Pharmaceuticals 6,147
Not applicableActive Not RecruitingNCT07289919
What this trial is testing

Exploring Sustainable Alternatives to Marine Oils With Echium and Ahiflower Oils

Who this might be right for
Cardiovascular (CV) RiskAtherosclerosesInflamation+2 more
University of Sao Paulo 15
Not applicableStudy completedNCT07088718
What this trial is testing

Prediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims Data

Who this might be right for
Type 2 DiabetesMajor Adverse Cardiac EventsCardiovascular (CV) Risk
Brigham and Women's Hospital 44,671
Not applicableStudy completedNCT07050407
What this trial is testing

Impact of Deferred Clinic Visits on Patients With Cardiovascular Comorbidities: A Prospective Cohort Study

Who this might be right for
Cardiovascular Risk Factor
Chinese University of Hong Kong 458
Not applicableStudy completedNCT00681759
What this trial is testing

An Observational Study of Burden of Upper GI-Symptoms in CV Risk Patients

Who this might be right for
Cardiovascular Disease
AstraZeneca 1,836
Not applicableEnded earlyNCT04050982
What this trial is testing

Feasibility Study to Improve AF Outcomes Using a Digital Application for CV Risk Reduction

Who this might be right for
Atrial Fibrillation
Stanford University 11
Large-scale testing (Phase 3)Study completedNCT03814187
What this trial is testing

Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C

Who this might be right for
ASCVDElevated CholesterolHeterozygous Familial Hypercholesterolemia+1 more
Novartis Pharmaceuticals 3,275
Large-scale testing (Phase 3)Study completedNCT02666664
What this trial is testing

Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)

Who this might be right for
HypercholesterolemiaAtherosclerotic Cardiovascular Diseases
Esperion Therapeutics, Inc. 2,230
Not applicableStudy completedNCT05775822
What this trial is testing

Coronary Artery Calcium and Cardiovascular Risk Factors Analysis After RT or Breast Cancer

Who this might be right for
Breast Cancer
Centro Cardiologico Monzino 92
Not applicableStudy completedNCT00921752
What this trial is testing

C2 -CORVUS Cholesterol-Control (C2) Controlled Targets for High Vascular Risk Patients Using Effective Statins (CORVUS)

Who this might be right for
Cardiovascular Risk
AstraZeneca 1,500
Not applicableLooking for participantsNCT07034274
What this trial is testing

National Tunisian Clinical Registry on CardioVascular Secondary Prevention Clinical

Who this might be right for
Secondary PreventionCHDCV Risk
Dacima Consulting 5,000
Not applicableStudy completedNCT03797885
What this trial is testing

People With Type 2 Diabetes Who Have Diseases That Affect the Heart and Blood Vessels. The Study Will Also Look at the Treatment of a Group of These People in Hospitals in Portugal

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 730
Large-scale testing (Phase 3)Study completedNCT01709513
What this trial is testing

Study of Alirocumab (REGN727/SAR236553) in Patients With Primary Hypercholesterolemia and Moderate, High, or Very High Cardiovascular (CV) Risk, Who Are Intolerant to Statins (ODYSSEY ALTERNATIVE)

Who this might be right for
Hypercholesterolemia
Regeneron Pharmaceuticals 314
Not applicableStudy completedNCT00648284
What this trial is testing

Cardiovascular (CV) Risk Evaluation In Type 2 Diabetes Subjects

Who this might be right for
Type 2 Diabetes MellitusCV Risk
GlaxoSmithKline 1,100
Not applicableStudy completedNCT05384834
What this trial is testing

Incorporating CV Risk Assessment in AYA Visits

Who this might be right for
Cardiovascular Diseases
Emory University 60
Not applicableLooking for participantsNCT07356817
What this trial is testing

Cardiovascular Risk Assessment in Young Women After Index Pregnancy With and Without Placental Complications

Who this might be right for
Cardiovascular (CV) RiskPreeclampsia (PE)Fetal Weight
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 1,260
Not applicableLooking for participantsNCT07187947
What this trial is testing

Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway

Who this might be right for
Gender IncongruenceCardiovascular (CV) RiskCardiovascular Disease Risk Factor+4 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 500
Load More Results